Hemorrhagic stroke laboratory findings: Difference between revisions

	Hemorrhagic stroke Microchapters
Main Stroke Page
Ischemic Stroke Page
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Stroke from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Emergency Diagnosis and Assessment
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
CT
MRI
Other Imaging Findings
Treatment
Early Assessment
NIH Stroke Scale
Management
Surgery
Rehabilitation
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
AHA/ASA Guidelines for the Management of Spontaneous Intracerebral Hemorrhage (2015) Management of ICH
AHA/ASA Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage (2012) Management of aSAH
AHA/ASA Guideline Recommendation for the Primary Prevention of Stroke (2014) Primary Prevention of Stroke
AHA/ASA Guideline Recommendations for Prevention of Stroke in Women (2014) Overview Sex-Specific Risk Factors Pregnancy and Complications Cerebral Venous Thrombosis Oral Contraceptives Menopause and Postmenopausal Hormonal Therapy Risk Factors Commoner in Women Migraine with Aura Obesity, Metabolic Syndrome, and Lifestyle Factors Atrial Fibrillation Prevention
Case Studies
Case #1
Hemorrhagic stroke laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hemorrhagic stroke laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hemorrhagic stroke laboratory findings
CDC on Hemorrhagic stroke laboratory findings
Hemorrhagic stroke laboratory findings in the news
Blogs on Hemorrhagic stroke laboratory findings
Directions to Hospitals Treating Stroke
Risk calculators and risk factors for Hemorrhagic stroke laboratory findings

VisualWikitext

Revision as of 15:54, 30 November 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Laboratory findings


Blood test	Test result	Rationale
Complete blood count and platelet	Leukocytosis Polycythemia Thrombocytopenia	Monitor for infection Assess hematocrit and platelet count to identify hemorrhagic risk and complications
BMP/Osmolarity	Increased or decreased serum NA2+, K+, Ca2+ Change in osmolarity	Monitor osmolarity for guidance of osmotic diuresis
PT/APTT/INR^[1]^[2]^[3]	Increased PT/APTT/INR	Identify a coagulopathy
BUN/Creatinine^[4]	Increased BUN and creatinine	May be associated with poor prognosis in patients with intracerebral hemorrhage and hematoma expansion
Toxicology screen/Serum alcohol level	Increased levels of serum	Identify illicit drug use or excessive alcohol Identify exogenous toxins that can cause intracerebral hemorrhage (ICH)

HbA1C	Increased levels of HbA1c
Blood glucose levels^[5]	Increased or decreased levels of blood glucose	May be associated with poor prognosis in patients with Intracerebral hemorrhage
Cardiac enzymes^[6]^[7]	Increased serum levels of Trop I, Trop T, CK-MB	May suggest ongoing myocardial ischemia (left ventricular ischemia)
Pregnancy test	Serum and urine B-HCG	Rule out pregnancy in all female patients with hemorrhagic stroke

References

↑ Cucchiara B, Messe S, Sansing L, Kasner S, Lyden P, CHANT Investigators (2008). "Hematoma growth in oral anticoagulant related intracerebral hemorrhage". Stroke. 39 (11): 2993–6. doi:10.1161/STROKEAHA.108.520668. PMID 18703803.
↑ Broderick JP, Diringer MN, Hill MD, Brun NC, Mayer SA, Steiner T; et al. (2007). "Determinants of intracerebral hemorrhage growth: an exploratory analysis". Stroke. 38 (3): 1072–5. doi:10.1161/01.STR.0000258078.35316.30. PMID 17290026.
↑ Flaherty ML, Tao H, Haverbusch M, Sekar P, Kleindorfer D, Kissela B; et al. (2008). "Warfarin use leads to larger intracerebral hematomas". Neurology. 71 (14): 1084–9. doi:10.1212/01.wnl.0000326895.58992.27. PMC 2668872. PMID 18824672.
↑ Miller CM, Vespa PM, McArthur DL, Hirt D, Etchepare M (2007). "Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduced levels of extracellular cerebral glutamate and unchanged lactate pyruvate ratios". Neurocrit Care. 6 (1): 22–9. doi:10.1385/NCC:6:1:22. PMID 17356187.
↑ Sawyer GJ, Fabre JW (1997). "Indirect T-cell allorecognition and the mechanisms of immunosuppression by allogeneic blood transfusions". Transpl Int. 10 (4): 276–83. PMID 9249937.
↑ Davis AM, Natelson BH (1993). "Brain-heart interactions. The neurocardiology of arrhythmia and sudden cardiac death". Tex Heart Inst J. 20 (3): 158–69. PMC 325088. PMID 8219819.
↑ Hasegawa K, Fix ML, Wendell L, Schwab K, Ay H, Smith EE; et al. (2012). "Ischemic-appearing electrocardiographic changes predict myocardial injury in patients with intracerebral hemorrhage". Am J Emerg Med. 30 (4): 545–52. doi:10.1016/j.ajem.2011.02.007. PMC 3684165. PMID 21450435.

Template:WS Template:WH

[pmid18703803-1] Cucchiara B, Messe S, Sansing L, Kasner S, Lyden P, CHANT Investigators (2008). "Hematoma growth in oral anticoagulant related intracerebral hemorrhage". Stroke. 39 (11): 2993–6. doi:10.1161/STROKEAHA.108.520668. PMID 18703803.

[pmid17290026-2] Broderick JP, Diringer MN, Hill MD, Brun NC, Mayer SA, Steiner T; et al. (2007). "Determinants of intracerebral hemorrhage growth: an exploratory analysis". Stroke. 38 (3): 1072–5. doi:10.1161/01.STR.0000258078.35316.30. PMID 17290026.

[pmid18824672-3] Flaherty ML, Tao H, Haverbusch M, Sekar P, Kleindorfer D, Kissela B; et al. (2008). "Warfarin use leads to larger intracerebral hematomas". Neurology. 71 (14): 1084–9. doi:10.1212/01.wnl.0000326895.58992.27. PMC 2668872. PMID 18824672.

[pmid17356187-4] Miller CM, Vespa PM, McArthur DL, Hirt D, Etchepare M (2007). "Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduced levels of extracellular cerebral glutamate and unchanged lactate pyruvate ratios". Neurocrit Care. 6 (1): 22–9. doi:10.1385/NCC:6:1:22. PMID 17356187.

[pmid9249937-5] Sawyer GJ, Fabre JW (1997). "Indirect T-cell allorecognition and the mechanisms of immunosuppression by allogeneic blood transfusions". Transpl Int. 10 (4): 276–83. PMID 9249937.

[pmid8219819-6] Davis AM, Natelson BH (1993). "Brain-heart interactions. The neurocardiology of arrhythmia and sudden cardiac death". Tex Heart Inst J. 20 (3): 158–69. PMC 325088. PMID 8219819.

[pmid21450435-7] Hasegawa K, Fix ML, Wendell L, Schwab K, Ay H, Smith EE; et al. (2012). "Ischemic-appearing electrocardiographic changes predict myocardial injury in patients with intracerebral hemorrhage". Am J Emerg Med. 30 (4): 545–52. doi:10.1016/j.ajem.2011.02.007. PMC 3684165. PMID 21450435.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

@@ Line 81: / Line 81: @@
 |-
 |}
 ==References==

Hemorrhagic stroke laboratory findings: Difference between revisions

Revision as of 15:54, 30 November 2016

Overview

Laboratory findings

References

Navigation menu